Singapore markets close in 3 hours 51 minutes
Straits Times Index
3,298.09 +7.39 (+0.22%) Nikkei
38,099.49 -129.62 (-0.34%) Hang Seng
19,052.14 +88.46 (+0.47%) FTSE 100
8,433.76 +261.61 (+3.20%) Bitcoin USD
60,913.23 -95.40 (-0.16%) CMC Crypto 200
1,256.79 -55.84 (-4.26%)
Ikena Oncology, Inc. (IKNA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 62.25M |
| Enterprise value | -102.47M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 5.88 |
| Price/book (mrq) | 0.37 |
| Enterprise value/revenue | -0.28 |
| Enterprise value/EBITDA | 0.06 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.34 |
| 52-week change 3 | -81.57% |
| S&P500 52-week change 3 | 26.27% |
| 52-week high 3 | 7.3800 |
| 52-week low 3 | 1.0200 |
| 50-day moving average 3 | 1.3853 |
| 200-day moving average 3 | 2.5738 |
Share statistics
| Avg vol (3-month) 3 | 398.07k |
| Avg vol (10-day) 3 | 204.83k |
| Shares outstanding 5 | 48.26M |
| Implied shares outstanding 6 | 50.13M |
| Float 8 | 17.95M |
| % held by insiders 1 | 7.00% |
| % held by institutions 1 | 102.11% |
| Shares short (30 Apr 2024) 4 | 1.52M |
| Short ratio (30 Apr 2024) 4 | 6.83 |
| Short % of float (30 Apr 2024) 4 | 3.94% |
| Short % of shares outstanding (30 Apr 2024) 4 | 3.14% |
| Shares short (prior month 28 Mar 2024) 4 | 1.25M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -3,324.43% |
Management effectiveness
| Return on assets (ttm) | -25.87% |
| Return on equity (ttm) | -43.04% |
Income statement
| Revenue (ttm) | 9.16M |
| Revenue per share (ttm) | 0.22 |
| Quarterly revenue growth (yoy) | -87.90% |
| Gross profit (ttm) | N/A |
| EBITDA | -74.4M |
| Net income avi to common (ttm) | -68.17M |
| Diluted EPS (ttm) | -1.6300 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 175.46M |
| Total cash per share (mrq) | 3.64 |
| Total debt (mrq) | 10.74M |
| Total debt/equity (mrq) | 6.33% |
| Current ratio (mrq) | 12.58 |
| Book value per share (mrq) | 3.52 |
Cash flow statement
| Operating cash flow (ttm) | -79.74M |
| Levered free cash flow (ttm) | -47.98M |
© 2024 Yahoo. All rights reserved.